ATM and gastric cancer: The frequency of ATM deleterious mutations was significantly higher in the gastric cancer patients than that in general population (9/335 for TCGA gastric cancer data vs. 6/2054 for 1000 genomes data; odds ratio = 9.41;the Fisher exact test, p = 0.0000435).